Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry.
Mandelkow T, Bady E, Lurati MCJ, Raedler JB, Müller JH, Huang Z, Vettorazzi E, Lennartz M, Clauditz TS, Lebok P, Steinhilper L, Woelber L, Sauter G, Berkes E, Bühler S, Paluchowski P, Heilenkötter U, Müller V, Schmalfeldt B, von der Assen A, Jacobsen F, Krech T, Krech RH, Simon R, Bernreuther C, Steurer S, Burandt E, Blessin NC. Mandelkow T, et al. Among authors: heilenkotter u. Biomedicines. 2023 Nov 29;11(12):3175. doi: 10.3390/biomedicines11123175. Biomedicines. 2023. PMID: 38137396 Free PMC article.
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer.
Weidemann S, Gorbokon N, Lennartz M, Hube-Magg C, Fraune C, Bernreuther C, Clauditz TS, Jacobsen F, Jansen K, Schmalfeldt B, Wölber L, Paluchowski P, Berkes E, Heilenkötter U, Sauter G, Uhlig R, Wilczak W, Steurer S, Simon R, Krech T, Marx A, Burandt E, Lebok P. Weidemann S, et al. Among authors: heilenkotter u. Appl Immunohistochem Mol Morphol. 2023 Feb 1;31(2):77-83. doi: 10.1097/PAI.0000000000001097. Epub 2023 Jan 9. Appl Immunohistochem Mol Morphol. 2023. PMID: 36728364 Free PMC article.
[A rare differential diagnosis of lower abdominal pain in pediatrics].
Müller S, Hillebrand G, Wördehoff R, Heilenkötter U, Neipp M. Müller S, et al. Among authors: heilenkotter u. Chirurgie (Heidelb). 2022 Jul;93(7):711-713. doi: 10.1007/s00104-022-01589-9. Epub 2022 Mar 31. Chirurgie (Heidelb). 2022. PMID: 35357552 German. No abstract available.
6q deletion is frequent but unrelated to patient prognosis in breast cancer.
Lebok P, Bönte H, Kluth M, Möller-Koop C, Witzel I, Wölber L, Paluchowski P, Wilke C, Heilenkötter U, Müller V, Schmalfeldt B, Simon R, Sauter G, Terracciano L, Krech RH, von der Assen A, Burandt E. Lebok P, et al. Among authors: heilenkotter u. Breast Cancer. 2022 Mar;29(2):216-223. doi: 10.1007/s12282-021-01301-5. Epub 2021 Oct 8. Breast Cancer. 2022. PMID: 34625909 Free PMC article.
High mitochondrial content is associated with breast cancer aggressiveness.
Lebok P, Schütt K, Kluth M, Witzel I, Wölber L, Paluchowski P, Terracciano L, Wilke C, Heilenkötter U, Müller V, Schmalfeldt B, Simon R, Sauter G, Von Leffern I, Krech T, Krech RH, Jacobsen F, Burandt E. Lebok P, et al. Among authors: heilenkotter u. Mol Clin Oncol. 2021 Oct;15(4):203. doi: 10.3892/mco.2021.2365. Epub 2021 Aug 8. Mol Clin Oncol. 2021. PMID: 34462659 Free PMC article.
MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer.
Rico SD, Schmalfeldt B, Müller V, Wölber L, Witzel I, Paluchowski P, von Leffern I, Heilenkötter U, Jacobsen F, Bernreuther C, Clauditz T, Simon R, Steurer S, Burandt E, Marx AH, Krech T. Rico SD, et al. Among authors: heilenkotter u. Pathol Res Pract. 2021 Aug;224:153533. doi: 10.1016/j.prp.2021.153533. Epub 2021 Jun 21. Pathol Res Pract. 2021. PMID: 34171599
High homogeneity of MMR deficiency in ovarian cancer.
Fraune C, Rosebrock J, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Höflmayer D, Schmalfeldt B, Müller V, Wölber L, Witzel I, Paluchowski P, Wilke C, Heilenkötter U, von Leffern I, Clauditz TS, Wilczak W, Sauter G, Steurer S, Burandt E. Fraune C, et al. Among authors: heilenkotter u. Gynecol Oncol. 2020 Mar;156(3):669-675. doi: 10.1016/j.ygyno.2019.12.031. Epub 2020 Jan 8. Gynecol Oncol. 2020. PMID: 31924330
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
Kind S, Jaretzke A, Büscheck F, Möller K, Dum D, Höflmayer D, Hinsch A, Weidemann S, Fraune C, Möller-Koop C, Hube-Magg C, Simon R, Wilczak W, Lebok P, Witzel I, Müller V, Schmalfeldt B, Paluchowski P, Wilke C, Heilenkötter U, von Leffern I, Krech T, Krech RH, von der Assen A, Bawahab AA, Burandt E. Kind S, et al. Among authors: heilenkotter u. Mol Carcinog. 2019 Dec;58(12):2306-2315. doi: 10.1002/mc.23119. Epub 2019 Sep 23. Mol Carcinog. 2019. PMID: 31545001
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
Lebok P, von Hassel A, Meiners J, Hube-Magg C, Simon R, Höflmayer D, Hinsch A, Dum D, Fraune C, Göbel C, Möller K, Sauter G, Jacobsen F, Büscheck F, Prien K, Krech T, Krech RH, von der Assen A, Wölber L, Witzel I, Schmalfeldt B, Geist S, Paluchoswski P, Wilke C, Heilenkötter U, Terracciano L, Müller V, Wilczak W, Burandt EC. Lebok P, et al. Among authors: heilenkotter u. Aging (Albany NY). 2019 Sep 18;11(18):7796-7804. doi: 10.18632/aging.102287. Epub 2019 Sep 18. Aging (Albany NY). 2019. PMID: 31533087 Free PMC article.
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.
Lebok P, Roming M, Kluth M, Koop C, Özden C, Taskin B, Hussein K, Lebeau A, Witzel I, Wölber L, Geist S, Paluchowski P, Wilke C, Heilenkötter U, Müller V, Schmalfeldt B, Simon R, Sauter G, Terracciano L, Krech RH, von der Assen A, Burandt E. Lebok P, et al. Among authors: heilenkotter u. Oncotarget. 2016 Dec 6;7(49):81322-81331. doi: 10.18632/oncotarget.13227. Oncotarget. 2016. PMID: 27835607 Free PMC article.
24 results